Sign Up to like & get
recommendations!
0
Published in 2020 at "Neuro-oncology"
DOI: 10.1093/neuonc/noaa215.649
Abstract: Current WHO guidelines emphasize classification of diffuse gliomas by genetic alterations into three subgroups: 1) IDH-wildtype; 2) IDH-mutant, 1p/19q-codeleted; and 3) IDH-mutant, 1p/19q-non-codeleted. Non-invasive genetic characterization can benefit patients with inoperable lesions or who are…
read more here.
Keywords:
gliomas genetic;
idh mutant;
non enhancing;
idh wildtype ... See more keywords